首页> 外文期刊>Transplantation Proceedings >Late occurrence of pleural and peritoneal effusion due to Mycobacterium tuberculosis infection (TB) in a patient with posttransplantation recurrent HCV chronic hepatitis: safety of peginterferon and ribavirin treatment after recovery of TB:- a case report.
【24h】

Late occurrence of pleural and peritoneal effusion due to Mycobacterium tuberculosis infection (TB) in a patient with posttransplantation recurrent HCV chronic hepatitis: safety of peginterferon and ribavirin treatment after recovery of TB:- a case report.

机译:移植后复发HCV慢性肝炎患者因结核分枝杆菌感染(TB)导致胸膜和腹膜积液的发生较晚:结核病恢复后聚乙二醇干扰素和利巴韦林治疗的安全性:病例报告。

获取原文
获取原文并翻译 | 示例
       

摘要

The late occurrence of a large and often long-lasting effusion in the pleural and peritoneal cavities after liver transplantation is an uncommon and poorly understood complication. Even rarer (1%) is the incidence of Mycobacterium tuberculosis (MT) in Western world series. Herein we have described a case of massive pleural effusion and ascites due to MT occurring 22 months after liver transplantation for hepatitis C virus (HCV) cirrhosis. The infection was successfully treated with no hepatotoxicity or rejection, so that it was possible to start antiviral treatment with peginterferon and ribavirin for recurrent HCV without reactivation of MT infection.
机译:肝移植后胸膜和腹膜腔中大量并通常持续很长时间的积液的晚期发生是罕见的并且了解不多的并发症。西方世界系列中结核分枝杆菌(MT)的发病率甚至更低(<1%)。本文中,我们描述了由于丙型肝炎病毒(HCV)肝硬化肝移植后22个月发生MT引起的大量胸腔积液和腹水的情况。感染已成功治疗,没有肝毒性或排斥反应,因此可以用聚乙二醇干扰素和利巴韦林开始抗病毒治疗复发的HCV,而无需重新激活MT感染。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号